| DUK |
Report |
Adjusted EPS |
IN-LINE |
pred ~$1.30 vs. cons $1.29 |
MEDIUM |
| DUK |
Report |
Revenue |
IN-LINE |
pred ~$7.70B vs. cons $7.66B |
LOW |
| DUK |
Report |
Executed data-center ESAs (GW signed) |
BEAT |
pred ~8.5 GW vs. prior/implied cons ~7.6 GW |
MEDIUM |
| DUK |
Guide |
FY2026 adjusted EPS guidance |
UNCHANGED |
guide $6.55–$6.80 (mid $6.68) vs. cons $6.71 (FY2026) |
HIGH |
| DUK |
Guide |
Long-term EPS growth (top-half from 2028) |
UNCHANGED |
guide 5–7% vs. cons ~6% (2025–2030 CAGR) |
MEDIUM |
| DUK |
Guide |
DEC NC rate case outcome (already settled 7/17) |
BETTER |
settled 9.8% ROE, $496M/2yr req vs. original $1,002M ask (DEC NC, rates 1/1/2027) |
HIGH |
| DUK |
Guide |
Late-stage data-center pipeline |
BETTER |
guide ~16 GW vs. prior 15.4 GW (late-stage pipeline) |
LOW |
| DUK |
Guide |
Five-year capital plan |
UNCHANGED |
guide ~$103B vs. prior $103B (2025–2029 capex plan) |
MEDIUM |
| DUK |
Return |
Day-1 residual (stock − beta × S&P 500) |
+0.4% |
— |
LOW |
| DUK |
Return |
5-day cumulative residual |
+0.6% (STABILIZE) |
Q2 is DUK's seasonally light, low-stakes print and the single biggest near-term catalyst — the DEC NC rate case — was already resolved constructively on 7/17 (9.8% ROE, rates 1/1/27), so it is de-risked rather than a fresh surprise. With FY26 guide ($6.55–6.80) and the 5–7% LT algo reaffirmed and consensus ($6.71) already inside the range, there are no implicit out-period cuts to pull estimates down; if anything, higher signed data-center ESAs supply modest upward bias. Absent a revision impulse, the low-beta name mean-reverts around its pre-print level after the initial reaction, though a still-soft regulated-utility tape (SO/NEE weak) caps upside — hence stabilize, not follow-through. |
LOW |